loader
Please Wait
Applying Filters...

Seqens Seqens

X

Approved Drug Products containing 209371 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 AUROBINDO PHARMA (2)

filter

01 FOR SUSPENSION;ORAL (2)

filter

01 RX (2)

filter

01 AMOXICILLIN AND CLAVULANATE POTASSIUM (2)

filter

01 No (2)

URL Supplier Web Content
FOR SUSPENSION; OR...
125MG/5ML;EQ 31.25...
2019-04-19
209371
AMOXICILLIN AND CL...
RX
No
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
FOR SUSPENSION; OR...
250MG/5ML;EQ 62.5M...
2019-04-19
209371
AMOXICILLIN AND CL...
RX
No
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 209371

Looking for FDA Orange Book APPLICATION 209371 2

19

Aurobindo Pharma Limited, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

One of their notable products is AMOXICILLIN; CLAVULANATE POTASSIUM, with a corresponding application number 209371.

Regulatory Information RX

With a dosage strength 125MG/5ML;EQ 31.25MG BASE/5ML

Dosage Form Route FOR SUSPENSION; ORAL

Reference Listed Drug No

Approved since 2019-04-19

Therapeutic Equivalence (TE) Code AB

18

Aurobindo Pharma Limited, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

One of their notable products is AMOXICILLIN; CLAVULANATE POTASSIUM, with a corresponding application number 209371.

Regulatory Information RX

With a dosage strength 250MG/5ML;EQ 62.5MG BASE/5ML

Dosage Form Route FOR SUSPENSION; ORAL

Reference Listed Drug No

Approved since 2019-04-19

Therapeutic Equivalence (TE) Code AB

Post Enquiry
POST ENQUIRY